Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCMII
NCT04476901Phase 2Active, not recruiting
- Start
- May 2021
- Primary completion
- Apr 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic human mesenchymal stem cells in dilated cardiomyopathy (DCM). Started May 2021; status: active, not recruiting.
02
Drugs
allogeneic human mesenchymal stem cells
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT04476901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04476901.